ProShare Advisors’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

ProShare Advisors’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,326	Closed	-$207K	–	2037
2023 Q4	$207K	Buy	+3,326	New	+$82.7K	﹤0.01%	1616

ProShare Advisors's RYZB Position: Q1 2024 in Review

ProShare Advisors sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 3,326 shares — an estimated $207K sold.

ProShare Advisors first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $207K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

ProShare Advisors reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
ProShare Advisors sold 3,326 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $207K.
ProShare Advisors first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
ProShare Advisors's RayzeBio, Inc. Common Stock position peaked at $207K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.